Human PSCA/PRO232 ORF/cDNA clone-Lentivirus particle (NM_005672)

Cat. No.: vGMLP000992

Pre-made Human PSCA/PRO232 Lentiviral expression plasmid for PSCA lentivirus packaging, PSCA lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to PSCA/PRO232 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP000992 Human PSCA Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP000992
Gene Name PSCA
Accession Number NM_005672
Gene ID 8000
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 345 bp
Gene Alias PRO232
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCAGGCTTGGCCCTGCAGCCAGGCACTGCCCTGCTGTGCTACTCCTGCAAAGCCCAGGTGAGCAACGAGGACTGCCTGCAGGTGGAGAACTGCACCCAGCTGGGGGAGCAGTGCTGGACCGCGCGCATCCGCGCAGTTGGCCTCCTGACCGTCATCAGCAAAGGCTGCAGCTTGAACTGCGTGGATGACTCACAGGACTACTACGTGGGCAAGAAGAACATCACGTGCTGTGACACCGACTTGTGCAACGCCAGCGGGGCCCATGCCCTGCAGCCGGCTGCTGCCATCCTTGCGCTGCTCCCTGCACTCGGCCTGCTGCTCTGGGGACCCGGCCAGCTCTAG
ORF Protein Sequence MAGLALQPGTALLCYSCKAQVSNEDCLQVENCTQLGEQCWTARIRAVGLLTVISKGCSLNCVDDSQDYYVGKKNITCCDTDLCNASGAHALQPAAAILALLPALGLLLWGPGQL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T23953-Ab Anti-PSCA/ PRO232 monoclonal antibody
    Target Antigen GM-Tg-g-T23953-Ag PSCA VLP (virus-like particle)
    ORF Viral Vector pGMLP000992 Human PSCA Lentivirus plasmid
    ORF Viral Vector pGMLP001836 Human PSCA Lentivirus plasmid
    ORF Viral Vector vGMLP000992 Human PSCA Lentivirus particle
    ORF Viral Vector vGMLP001836 Human PSCA Lentivirus particle


    Target information

    Target ID GM-T23953
    Target Name PSCA
    Gene Group Identifier
    （Target Gene ID in Homo species)         		8000
    Gene ID 100063721 (Equus caballus), 101097300 (Felis catus), 482068 (Canis lupus familiaris), 680210 (Rattus norvegicus)
    703505 (Macaca mulatta), 72373 (Mus musculus), 8000 (Homo sapiens)
    Gene Symbols & Synonyms PSCA,Psca,2210408B04Rik,PRO232,lncPSCA
    Target Alternative Names 2210408B04Rik,PRO232,PSCA,Prostate stem cell antigen,Psca,lncPSCA
    Uniprot Accession O43653,P57096
    Additional SwissProt Accessions: P57096,O43653
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, Immuno-oncology Target
    Disease cancer, Prostate Cancer, Type 2 diabetes mellitus with diabetic nephropathy
    Disease from KEGG
    Gene Ensembl ENSECAG00000006143, ENSCAFG00845014135, ENSMMUG00000028899, ENSMUSG00000022598, ENSG00000167653
    Target Classification Checkpoint-Immuno Oncology


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.